Sandborn, W J <br/><br/>
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jul 2007 
 - 205-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2007.03361.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Colitis, Ulcerative--drug therapy<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Mesalamine--therapeutic use<br/>Middle Aged<br/>Randomized Controlled Trials as Topic<br/>Remission Induction<br/>Severity of Illness Index